Your browser doesn't support javascript.
A fourth dose of the mRNA-1273 SARS-CoV-2 vaccine improves serum neutralization against the Delta variant in kidney transplant recipients.
Benotmane, Ilies; Bruel, Timothée; Planas, Delphine; Fafi-Kremer, Samira; Schwartz, Olivier; Caillard, Sophie.
  • Benotmane I; Department of Nephrology and Transplantation, Strasbourg University Hospital, Strasbourg, France. Electronic address: ilies.benotmane@chru-strasbourg.fr.
  • Bruel T; Institut Pasteur, Université de Paris, Centre national de la recherche scientifique (CNRS), Unité mixte de recherche (UMR) 3569, Virus and Immunity Unit, Paris, France; Vaccine Research Institute, Basic Division, Créteil, France.
  • Planas D; Institut Pasteur, Université de Paris, Centre national de la recherche scientifique (CNRS), Unité mixte de recherche (UMR) 3569, Virus and Immunity Unit, Paris, France; Vaccine Research Institute, Basic Division, Créteil, France.
  • Fafi-Kremer S; Department of Virology, Strasbourg University Hospital, Strasbourg, France.
  • Schwartz O; Institut Pasteur, Université de Paris, Centre national de la recherche scientifique (CNRS), Unité mixte de recherche (UMR) 3569, Virus and Immunity Unit, Paris, France; Vaccine Research Institute, Basic Division, Créteil, France.
  • Caillard S; Department of Nephrology and Transplantation, Strasbourg University Hospital, Strasbourg, France.
Kidney Int ; 101(5): 1073-1076, 2022 05.
Article in English | MEDLINE | ID: covidwho-1708696

Full text: Available Collection: International databases Database: MEDLINE Main subject: Kidney Transplantation / COVID-19 Topics: Vaccines / Variants Limits: Humans Language: English Journal: Kidney Int Year: 2022 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Kidney Transplantation / COVID-19 Topics: Vaccines / Variants Limits: Humans Language: English Journal: Kidney Int Year: 2022 Document Type: Article